Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growthin vitroandin vivo
Authors:
Open Access
- 19 June 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (47) , 28434-28444
Abstract
Oncotarget | https://doi.org/10.18632/oncotarget.25421 Shuhei Shinoda, Seiji Kaino, Shogo Amano, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki, Isao Sakaida Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivoKeywords
This publication has 31 references indexed in Scilit:
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II TrialJournal of Clinical Oncology, 2011
- Novel Thiosemicarbazone Iron Chelators Induce Up-Regulation and Phosphorylation of the Metastasis Suppressor N-myc Down-Stream Regulated Gene 1: A New Strategy for the Treatment of Pancreatic CancerMolecular Pharmacology, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancerInternational Journal of Cancer, 2006
- The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and CancerPharmacological Reviews, 2005
- Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cellsMolecular Cancer Therapeutics, 2005
- The role of iron in cell cycle progression and the proliferation of neoplastic cellsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2002
- Controlled Protein Degradation Regulates Ribonucleotide Reductase Activity in Proliferating Mammalian Cells during the Normal Cell Cycle and in Response to DNA Damage and Replication BlocksJournal of Biological Chemistry, 2000
- Cytotoxic and DNA‐inhibitory effects of iron chelators on human leukaemic cell linesHematological Oncology, 1986
- Reduction of RibonucleotidesAnnual Review of Biochemistry, 1979